Scope Fluidics S.A. (WSE:SCP)
Poland · Delayed Price · Currency is PLN 147.80
-1.80 (-1.20%)
Aug 14, 2025, 4:39 PM CET
Scope Fluidics Market Cap
Scope Fluidics has a market cap or net worth of 407.80 million as of August 14, 2025. Its market cap has decreased by -9.88% in one year.
Market Cap
407.80M
Enterprise Value
271.91M
Revenue
117.00K
Ranking
n/a
PE Ratio
6.66
Stock Price
147.80
Market Cap Chart
Since August 16, 2017, Scope Fluidics's market cap has increased from 41.31M to 407.80M, an increase of 887.07%. That is a compound annual growth rate of 33.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 407.80M | -8.78% |
| Dec 30, 2024 | 447.05M | -16.33% |
| Dec 29, 2023 | 534.28M | -5.54% |
| Dec 30, 2022 | 565.63M | 54.38% |
| Dec 30, 2021 | 366.40M | 1.04% |
| Dec 30, 2020 | 362.64M | 161.03% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.72B |
| NEUCA | 2.94B |
| Voxel | 1.87B |
| Synektik Spólka Akcyjna | 1.81B |
| Celon Pharma | 1.24B |
| Ryvu Therapeutics | 700.54M |
| Selvita | 607.57M |
| Centrum Medyczne ENEL-MED | 545.81M |